Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
New targets for therapy in breast cancer: mammalian target of rapamycin (mTOR) antagonists.
Carraway H, Hidalgo M
Breast Cancer Res 2004, 6:219-24
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Review    
The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention
Alao JP
Molecular Cancer 2007, 6:24 (2 April 2007)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
2.


Viewpoint    
Determining sensitivity to rapamycin and its analogues in breast cancer patients
Witton CJ
Breast Cancer Res 2005, 7:41-42 (17 December 2004)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles]

This article is also cited by a further 5 articles in PubMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.